Swedish Pharmaceuticals & Biotech Potentially Undervalued Companies

Swedish Orphan Biovitrum

Market Cap: SEK 100.4b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Newbury Pharmaceuticals

Market Cap: SEK 74.7m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Camurus

Market Cap: SEK 34.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.

Devyser Diagnostics

Market Cap: SEK 1.6b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Vitrolife

Market Cap: SEK 20.4b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

AstraZeneca

Market Cap: SEK 164.6b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

BICO Group

Market Cap: SEK 2.6b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Saniona

Market Cap: SEK 979.8m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, Germany, Denmark, the United Kingdom, and Mexico.

NextCell Pharma

Market Cap: SEK 83.3m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

AroCell

Market Cap: SEK 126.2m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Biovica International

Market Cap: SEK 70.8m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs for the treatment of cancer.

Sprint Bioscience

Market Cap: SEK 42.0m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Ascelia Pharma

Market Cap: SEK 294.1m

A biotech company, focuses on orphan oncology treatments in Sweden.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Orexo

Market Cap: SEK 521.0m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally.

Corline Biomedical

Market Cap: SEK 266.9m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Nanologica

Market Cap: SEK 116.6m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

AcouSort

Market Cap: SEK 59.7m

A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.

Bonesupport Holding

Market Cap: SEK 19.7b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Xbrane Biopharma

Market Cap: SEK 299.2m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

Magle Chemoswed Holding

Market Cap: SEK 562.1m

Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.

SenzaGen

Market Cap: SEK 165.8m

Provides non-animal tests for assessing a substance’s allergenicity.

BioArctic

Market Cap: SEK 17.2b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

Oncopeptides

Market Cap: SEK 418.8m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

Biotage

Market Cap: SEK 11.3b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

MedCap

Market Cap: SEK 6.4b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.